Experimental congenital lipoid adrenal hyperplasia: prevention of anatomic defects produced by aminoglutethimide.
D000311:Adrenal Glands / Q000187:drug effects; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy*; D000616:Aminoglutethimide / Q000037:antagonists & inhibitors; D000814:Aniline Compounds / Q000037:antagonists & inhibitors*; D000818:Animals; D000927:Anticonvulsants / Q000037:antagonists & inhibitors*; D002784:Cholesterol / Q000378:metabolism; D003345:Corticosterone / Q000494:pharmacology*; D004195:Disease Models, Animal; D005260:Female; D005333:Fetus / Q000187:drug effects; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D007021:Hypospadias / Q000209:etiology; D008190:Lyases / Q000037:antagonists & inhibitors; D008297:Male; D009929:Organ Size; D010053:Ovary / Q000187:drug effects; D011247:Pregnancy; D011728:Pyridones / Q000037:antagonists & inhibitors*; D051381:Rats; D013737:Testis / Q000187:drug effects; D013739:Testosterone / Q000494:pharmacology*
D000814:Aniline Compounds; D000927:Anticonvulsants; D011728:Pyridones; D000616:Aminoglutethimide; D013739:Testosterone; D002784:Cholesterol; D006913:Hydroxysteroid Dehydrogenases; D008190:Lyases; D003345:Corticosterone